FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

John Reilly

Research Profile

Disorders

Physiology

Mutation

Procedures

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Claire N Harrison; Richard Murrin; Deepti H Radia; John T Reilly; Nauman Butt; Peter Campbell; Eibhlin Conneally; Mark Drummond; Anthony R Green; Mary Frances McMullin
Diagnostic pathway for the investigation of thrombocytosis.
Anna L Godfrey; Beatriz Bellosillo; Carlos Besses; Fontanet Bijou; Jean-Michel Boiron; Peter J Campbell; Edwin Chen; Konstanze Döhner; Paola Guglielmelli; Claire N Harrison; Eric Lippert; Mary Frances McMullin; Christina A Ortmann; Francesca Pagano; John T Reilly; Yvonne Silber; Frank Stegelmann; Alessandro M Vannucchi; Anthony R Green
JAK2V617F homozygosity arises commonly and recurrently in PV and ET, but PV is characterized by expansion of a dominant homozygous subclone.
John T Reilly; Mallika Sekhar; Bridget Wilkins; Philip A Beer; Nauman Butt; Eibhlean Conneally; Andrew Duncombe; Marie H Gilleece; Anthony R Green; Georgina W Hall; Claire N Harrison; Steven Knapper; Mary Frances McMullin; Adam Mead; Ruben A Mesa; N George Michaeel
Guideline for the diagnosis and management of myelofibrosis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of John Reilly (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Claire N Harrison; Richard Murrin; Deepti H Radia; John T Reilly; Nauman Butt; Peter Campbell; Eibhlin Conneally; Mark Drummond; Anthony R Green; Mary Frances McMullin
Diagnostic pathway for the investigation of thrombocytosis.
British journal of haematology 2013;161(4):604-6.
2012: Anna L Godfrey; Beatriz Bellosillo; Carlos Besses; Fontanet Bijou; Jean-Michel Boiron; Peter J Campbell; Edwin Chen; Konstanze Döhner; Paola Guglielmelli; Claire N Harrison; Eric Lippert; Mary Frances McMullin; Christina A Ortmann; Francesca Pagano; John T Reilly; Yvonne Silber; Frank Stegelmann; Alessandro M Vannucchi; Anthony R Green
JAK2V617F homozygosity arises commonly and recurrently in PV and ET, but PV is characterized by expansion of a dominant homozygous subclone.
Blood 2012;120(13):2704-7.
2012: John T Reilly; Mallika Sekhar; Bridget Wilkins; Philip A Beer; Nauman Butt; Eibhlean Conneally; Andrew Duncombe; Marie H Gilleece; Anthony R Green; Georgina W Hall; Claire N Harrison; Steven Knapper; Mary Frances McMullin; Adam Mead; Ruben A Mesa; N George Michaeel
Guideline for the diagnosis and management of myelofibrosis.
British journal of haematology 2012;158(4):453-71.
2012: John T Reilly
Current treatment practices for essential thrombocythemia: survey results from European hematologists/oncologists.
Hematology (Amsterdam, Netherlands) 2012;17(4):187-92.
2010: Daniel C Gilby; Hye-Youn Sung; Peter R Winship; Anne C Goodeve; John T Reilly; Endre Kiss-Toth
Tribbles-1 and -2 are tumour suppressors, down-regulated in human acute myeloid leukaemia.
Immunology letters 2010;130(1-2):115-24.
2010: Deepa R J Arachchillage; Christopher D Dalley; John T Reilly; G Wilson; Noel Collins; John A Snowden
Long-term dual donor derived haematopoietic reconstitution following double unrelated cord blood transplantation--single unit dominance is not always the case.
British journal of haematology 2010;149(2):298-9.
2009: John T Reilly
Anagrelide for the treatment of essential thrombocythemia: a survey among European hematologists/oncologists.
Hematology (Amsterdam, Netherlands) 2009;14(1):1-10.
2008: R J Cutting; E Welch; J Channer; Y Ezaydi; P Talley; John T Reilly; John A Snowden
Myelofibrosis as the initial presentation of donor-derived myelodysplastic syndrome/AML: failure of a lasting response to a second allogeneic transplant from the original donor.
Bone marrow transplantation 2008;42(9):631-3.
2008: John T Reilly
Pathogenetic insight and prognostic information from standard and molecular cytogenetic studies in the BCR-ABL-negative myeloproliferative neoplasms (MPNs).
Leukemia 2008;22(10):1818-27.
2008: Philip A Beer; Peter J Campbell; Linda Maree SCOTT; Anthony J Bench; Wendy N Erber; David Bareford; Bridget S Wilkins; John T Reilly; Hans Carl Hasselbalch; Richard Bowman; Keith Wheatley; Georgina Buck; Claire N Harrison; Anthony R Green
MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort.
Blood 2008;112(1):141-9.
2008: Giovanni Barosi; Ruben A Mesa; J Thiele; Francisco Cervantes; Peter J Campbell; Srdan Verstovsek; Brigitte Dupriez; Ross Levine; Francesco Passamonti; J Gotlib; John T Reilly; A M Vannucchi; C A Hanson; Lawrence Solberg; A Orazi; Ayalew Tefferi
Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the International Working Group for Myelofibrosis Research and Treatment.
Leukemia 2008;22(2):437-8.
2007: John T Reilly
Practical approach to treating essential thrombocythaemia: case studies.
European journal of haematology. Supplementum 2007;(68):40-2.
2007: John T Reilly
Implications of the consensus definition of clinical resistance and intolerance to hydroxyurea for clinical practice.
European journal of haematology. Supplementum 2007;(68):32-4.
2006: John T Reilly
Idiopathic myelofibrosis: pathogenesis to treatment.
Hematological oncology 2006;24(2):56-63.
2006: Clare L Walker; Liam Whitby; Vivian Granger; Ian Storie; John T Reilly; David Barnett
Flow rate calibration. III. The use of stabilized biostandards to calibrate the flow rate and calculate absolute CD4+ T-cell counts.
Cytometry. Part B, Clinical cytometry 2006;70(3):154-62.
2005: Muhammad Farid Johan; Anne C Goodeve; David T Bowen; Marion E Frew; John T Reilly
JAK2 V617F Mutation is uncommon in chronic myelomonocytic leukaemia.
British journal of haematology 2005;130(6):968.
2005: David Dingli; Francis H Grand; Victor Mahaffey; Jack L Spurbeck; Fiona M Ross; Ann Watmore; John T Reilly; Nicholas C P Cross; Gordon W Dewald; Ayalew Tefferi
Der(6)t(1;6)(q21-23;p21.3): a specific cytogenetic abnormality in myelofibrosis with myeloid metaplasia.
British journal of haematology 2005;130(2):229-32.
2005: Muhammad Farid Johan; David T Bowen; Marion E Frew; Anne C Goodeve; John T Reilly
Aberrant methylation of the negative regulators RASSFIA, SHP-1 and SOCS-1 in myelodysplastic syndromes and acute myeloid leukaemia.
British journal of haematology 2005;129(1):60-5.
2005: John T Reilly
Pathogenesis of acute myeloid leukaemia and inv(16)(p13;q22): a paradigm for understanding leukaemogenesis?
British journal of haematology 2005;128(1):18-34.
2004: Muhammad Farid Johan; Anne C Goodeve; John T Reilly
Activating loop mutations in the PDGFR alpha and beta genes are rare in core binding factor acute myeloid leukaemia.
British journal of haematology 2004;127(1):123-4.
2004: Muhammad Farid Johan; David T Bowen; Marion E Frew; Anne C Goodeve; Gill A Wilson; Ian R Peake; John T Reilly
Mutations in PTPN11 are uncommon in adult myelodysplastic syndromes and acute myeloid leukaemia.
British journal of haematology 2004;124(6):843-4.
2004: joost van veen; John T Reilly; S J Richards; Liam Whitby; Karen Goodfellow; Vivian Granger; D C Rees; David Barnett
Diagnosis of plasma cell leukaemia: findings of the UK NEQAS for Leucocyte Immunophenotyping scheme.
Clinical and laboratory haematology 2004;26(1):37-42.
2004: Peter J M Valk; David T Bowen; Marion E Frew; Anne C Goodeve; Bob Löwenberg; John T Reilly
Second hit mutations in the RTK/RAS signaling pathway in acute myeloid leukemia with inv(16).
Haematologica 2004;89(1):106.
2004: Ian Storie; Alex Sawle; Karen Goodfellow; Liam Whitby; Vivian Granger; Rosalie Y Ward; Janet Peel; Theresa Smart; John T Reilly; David Barnett
Perfect count: a novel approach for the single platform enumeration of absolute CD4+ T-lymphocytes.
Cytometry. Part B, Clinical cytometry 2004;57(1):47-52.
2003: John T Reilly
Receptor tyrosine kinases in normal and malignant haematopoiesis.
Blood reviews 2003;17(4):241-8.
2003: Faisel M Abu-Duhier; Anne C Goodeve; Gill A Wilson; Ian R Peake; John T Reilly
c-FMS mutational analysis in acute myeloid leukaemia.
British journal of haematology 2003;123(4):749-50.
2003: Ian Storie; Alex Sawle; Liam Whitby; Karen Goodfellow; Vivian Granger; John T Reilly; David Barnett
Flow rate calibration II: a clinical evaluation study using PanLeucoGating as a single-platform protocol.
Cytometry. Part B, Clinical cytometry 2003;55(1):8-13.
2003: Ian Storie; Alex Sawle; Karen Goodfellow; Liam Whitby; Vivian Granger; John T Reilly; David Barnett
Flow rate calibration I: a novel approach for performing absolute cell counts.
Cytometry. Part B, Clinical cytometry 2003;55(1):1-7.
2003: Rory S Care; Peter J M Valk; Anne C Goodeve; Faisel M Abu-Duhier; Wendy M C Geertsma-Kleinekoort; Gill A Wilson; Mamdooh A Gari; Ian R Peake; Bob Löwenberg; John T Reilly
Incidence and prognosis of c-KIT and FLT3 mutations in core binding factor (CBF) acute myeloid leukaemias.
British journal of haematology 2003;121(5):775-7.
2003: Faisel M Abu-Duhier; Anne C Goodeve; Rory S Care; Mamdooh A Gari; Gill A Wilson; Ian R Peake; John T Reilly
Mutational analysis of class III receptor tyrosine kinases (C-KIT, C-FMS, FLT3) in idiopathic myelofibrosis.
British journal of haematology 2003;120(3):464-70.
2003: John T Reilly
FLT3 and its role in the pathogenesis of acute myeloid leukaemia.
Leukemia & lymphoma 2003;44(1):1-7.
2002: Faisel M Abu-Duhier; Anne C Goodeve; Gill A Wilson; Rory S Carr; Ian R Peake; John T Reilly
FLT3 internal tandem duplication mutations are rare in agnogenic myeloid metaplasia.
Blood 2002;100(1):364.
2002: Karen Goodfellow; Ian Storie; Vivian Granger; Liam Whitby; Joanne Antcliffe; John T Reilly; David Barnett
The United Kingdom National External Quality Assessment Scheme gating and standardization strategy for use in residual WBC counting of WBC-reduced blood components.
Transfusion 2002;42(6):738-46.
2002: Liam Whitby; Vivian Granger; Ian Storie; Karen Goodfellow; Alex Sawle; John T Reilly; David Barnett
Quality control of CD4+ T-lymphocyte enumeration: results from the last 9 years of the United Kingdom National External Quality Assessment Scheme for Immune Monitoring (1993-2001).
Cytometry 2002;50(2):102-10.
2002: Muralikrishnan Srikant; joost van veen; Ajay Raithatha; John T Reilly
Cyclophosphamide-induced nail pigmentation.
British journal of haematology 2002;117(1):2.
2002: John T Reilly
Class III receptor tyrosine kinases: role in leukaemogenesis.
British journal of haematology 2002;116(4):744-57.
2002: John T Reilly
Cytogenetic and molecular genetic aspects of idiopathic myelofibrosis.
Acta haematologica 2002;108(3):113-9.
2002: John T Reilly
Chronic neutrophilic leukaemia: a distinct clinical entity?
British journal of haematology 2002;116(1):10-8.
2001: G Wilson; P Forrest; S Heppinstall; B N Green; Anne C Goodeve; Ian R Peake; John T Reilly; N Porter; D C Rees
A second case of Hb Renert [beta133(H11)Val --> Ala].
Hemoglobin 2001;25(3):337-40.
2001: Faisel M Abu-Duhier; Anne C Goodeve; Gill A Wilson; Rory S Care; Ian R Peake; John T Reilly
Genomic structure of human FLT3: implications for mutational analysis.
British journal of haematology 2001;113(4):1076-7.
2001: Faisel M Abu-Duhier; Anne C Goodeve; Gill A Wilson; Rory S Care; Ian R Peake; John T Reilly
Identification of novel FLT-3 Asp835 mutations in adult acute myeloid leukaemia.
British journal of haematology 2001;113(4):983-8.
2001: EJ Sinclair; E C Forrest; John T Reilly; Ann Watmore; A M Potter
Fluorescence in situ hybridization analysis of 25 cases of idiopathic myelofibrosis and two cases of secondary myelofibrosis: monoallelic loss of RB1, D13S319 and D13S25 loci associated with cytogenetic deletion and translocation involving 13q14.
British journal of haematology 2001;113(2):365-8.
2001: David Barnett; Karen Goodfellow; J Ginnever; Vivian Granger; Liam Whitby; John T Reilly
Low level leucocyte counting: a critical variable in the validation of leucodepleted blood transfusion components as highlighted by an external quality assessment study.
Clinical and laboratory haematology 2001;23(1):43-51.
2000: Gill A Wilson; Elisabeth A Vandenberghe; R C Pollitt; David C Rees; Anne C Goodeve; Ian R Peake; John T Reilly
Are aberrant BCR--ABL transcripts more common than previously thought?
British journal of haematology 2000;111(4):1109-11.
2000: David Rowe; Simon J Cotterill; Fiona M Ross; D J Bunyan; S J Vickers; J Bryon; Dominic J McMullan; M J Griffiths; John T Reilly; Elisabeth A Vandenberghe; G Wilson; Ann Watmore; Nick Bown
Cytogenetically cryptic AML1-ETO and CBF beta-MYH11 gene rearrangements: incidence in 412 cases of acute myeloid leukaemia.
British journal of haematology 2000;111(4):1051-6.
2000: Faisel M Abu-Duhier; Anne C Goodeve; Gill A Wilson; Mamdooh A Gari; Ian R Peake; David C Rees; Elisabeth A Vandenberghe; Peter R Winship; John T Reilly
FLT3 internal tandem duplication mutations in adult acute myeloid leukaemia define a high-risk group.
British journal of haematology 2000;111(1):190-5.
2000: M Leach; R M Parsons; John T Reilly; David A Winfield
Autoimmune thrombocytopenia: a complication of fludarabine therapy in lymphoproliferative disorders.
Clinical and laboratory haematology 2000;22(3):175-8.
2000: K S Charles; M Kanaa; David A Winfield; John T Reilly
Scrotal ulceration during all-trans retinoic (ATRA) therapy for acute promyelocytic leukaemia.
Clinical and laboratory haematology 2000;22(3):171-4.
2000: David Barnett; Ian Storie; Vivian Granger; Liam Whitby; John T Reilly; S Brough; S Garner; J Lawry; S Richards; A E Bell; B K Shenton
Standardization of lymphocyte antibody binding capacity - a multi-centre study.
Clinical and laboratory haematology 2000;22(2):89-96.
2000: David Barnett; Vivian Granger; Jaco Kraan; Liam Whitby; John T Reilly; S Papa; Jan W Gratama
Reduction of intra- and interlaboratory variation in CD34+ stem cell enumeration using stable test material, standard protocols and targeted training. DK34 Task Force of the European Working Group of Clinical Cell Analysis (EWGCCA).
British journal of haematology 2000;108(4):784-92.
1999: David Barnett; Vivian Granger; Liam Whitby; Ian Storie; John T Reilly
Absolute CD4+ T-lymphocyte and CD34+ stem cell counts by single-platform flow cytometry: the way forward.
British journal of haematology 1999;106(4):1059-62.
1998: John T Reilly
Pathogenesis and management of idiopathic myelofibrosis.
Baillière's clinical haematology 1998;11(4):751-67.
1998: David Barnett; Vivian Granger; Ian Storie; J Peel; R Pollitt; T Smart; John T Reilly
Quality assessment of CD34+ stem cell enumeration: experience of the United Kingdom National External Quality Assessment Scheme (UK NEQAS) using a unique stable whole blood preparation.
British journal of haematology 1998;102(2):553-65.
1998: M Leach; R M Parsons; John T Reilly; David A Winfield
Efficacy of urate oxidase (uricozyme) in tumour lysis induced urate nephropathy.
Clinical and laboratory haematology 1998;20(3):169-72.
1998: David Barnett; Ian Storie; G A Wilson; Vivian Granger; John T Reilly
Determination of leucocyte antibody binding capacity (ABC): the need for standardization.
Clinical and laboratory haematology 1998;20(3):155-64.
1997: John T Reilly
Idiopathic myelofibrosis: pathogenesis, natural history and management.
Blood reviews 1997;11(4):233-42.
1997: John T Reilly; John A Snowden; Ruth Spearing; P M Fitzgerald; N Jones; Ann Watmore; A Potter
Cytogenetic abnormalities and their prognostic significance in idiopathic myelofibrosis: a study of 106 cases.
British journal of haematology 1997;98(1):96-102.
1997: John A Snowden; J Poole; A J Bates; M Faulkner; V Day; David J Booker; Robert J Sokol; John T Reilly
The Rhnull phenotype in an English individual: haematological, serological and immunological studies.
Clinical and laboratory haematology 1997;19(2):143-8.
1996: David Barnett; Vivian Granger; P Mayr; Ian Storie; G A Wilson; John T Reilly
Evaluation of a novel stable whole blood quality control material for lymphocyte subset analysis: results from the UK NEQAS immune monitoring scheme.
Cytometry 1996;26(3):216-22.
1996: John T Reilly; E Vellenga; J T De Wolff
Interferon treatment in polycythaemia vera.
Leukemia & lymphoma 1996;22 Suppl 1():143-8.
1996: Andrew J Dalley; J M Smith; John T Reilly; S M Neil
Investigation of calmodulin and basic fibroblast growth factor (bFGF) in idiopathic myelofibrosis: evidence for a role of extracellular calmodulin in fibroblast proliferation.
British journal of haematology 1996;93(4):856-62.
1996: John T Reilly
Use and evaluation of leucocyte monoclonal antibodies in the diagnostic laboratory: a review.
Clinical and laboratory haematology 1996;18(1):1-5.
1996: P C Taylor; G Dolan; J P Ng; B Paul; R Collin; John T Reilly
Efficacy of recombinant interferon-alpha (rIFN-alpha) in polycythaemia vera: a study of 17 patients and an analysis of published data.
British journal of haematology 1996;92(1):55-9.
1995: Ian Storie; G A Wilson; Vivian Granger; David Barnett; John T Reilly
Circulating CD20dim T-lymphocytes increase with age: evidence for a memory cytotoxic phenotype.
Clinical and laboratory haematology 1995;17(4):323-8.
1995: John T Reilly; L Brindley; M Kay; S Fielding; A Kennedy; G Dolan; A Smith
Bone marrow and serum connective tissue polypeptides in idiopathic myelofibrosis.
Clinical and laboratory haematology 1995;17(1):35-9.
1995: John T Reilly; Vivian Granger; P F Temperton; David Barnett
Leukaemia immunophenotyping: effect of antibody source and fluorochrome on antigen detection.
Journal of clinical pathology 1995;48(2):186.
1994: John A Snowden; A Milford-Ward; John T Reilly
Symptomatic IgG3 deficiency successfully treated with intravenous immunoglobulin therapy.
Postgraduate medical journal 1994;70(830):924-6.
1994: M A Wodziński; John A Snowden; John T Reilly
Toxic megacolon complicating chemotherapy for acute myeloid leukaemia.
Postgraduate medical journal 1994;70(830):921-3.
1994: John T Reilly; G Wilson; David Barnett; A Watmore; A Potter
Karyotypic and ras gene mutational analysis in idiopathic myelofibrosis.
British journal of haematology 1994;88(3):575-81.
1994: John T Reilly
Pathogenesis of idiopathic myelofibrosis: present status and future directions.
British journal of haematology 1994;88(1):1-8.
1994: S Bhandari; M A Wodzinski; John T Reilly
Reversible digital clubbing in acute myeloid leukaemia.
Postgraduate medical journal 1994;70(824):457-8.
1994: J M Eastham; John T Reilly; Sheila Mac Neil
Raised urinary calmodulin levels in idiopathic myelofibrosis: possible implications for the aetiology of fibrosis.
British journal of haematology 1994;86(3):668-70.
1993: M A Wodziński; K D Bardhan; John T Reilly; P Cooper; F E Preston
Reduced tissue type plasminogen activator activity of the gastroduodenal mucosa in peptic ulcer disease.
Gut 1993;34(10):1310-4.
1993: John T Reilly; David Barnett; G Dolan; P Forrest; J Eastham; A Smith
Characterization of an acute micromegakaryocytic leukaemia: evidence for the pathogenesis of myelofibrosis.
British journal of haematology 1993;83(1):58-62.
1992: M A Wodzinski; K D Bardhan; P Cooper; John T Reilly; F E Preston
Mucosal plasminogen activator activity in peptic ulcer disease.
Annals of the New York Academy of Sciences 1992;667():181-2.
1992: John T Reilly
Pathogenesis of idiopathic myelofibrosis: role of growth factors.
Journal of clinical pathology 1992;45(6):461-4.
1991: John T Reilly; G Dolan
Proposed classification for the myelodysplasia/myelofibrosis syndromes.
British journal of haematology 1991;79(4):653.
1991: G Dolan; A P Jones; Aubrey Blumsohn; John T Reilly; M J Brown
Lead poisoning due to Asian ethnic treatment for impotence.
Journal of the Royal Society of Medicine 1991;84(10):630-1.
1991: G Dolan; J Smith; John T Reilly
Extrapulmonary lymphomatoid granulomatosis presenting as Pancoast's syndrome.
Postgraduate medical journal 1991;67(792):914-5.
1991: G Dolan; P L Forrest; J M Eastham; John T Reilly
Reduced platelet PDGF levels in idiopathic myelofibrosis.
British journal of haematology 1991;78(4):586-8.
1991: M A Wodzinski; K K Hampton; John T Reilly
Differential effect of G-CSF and GM-CSF in acquired chronic neutropenia.
British journal of haematology 1991;77(2):249-50.
1990: David Barnett; Vivian Granger; John T Reilly
Expression of the p75 interleukin-2 receptor (beta subunit) in acute and chronic leukaemia.
British journal of haematology 1990;76(2):314-5.
1990: J Storr; G Dolan; E Coustan-Smith; David Barnett; John T Reilly
Value of monoclonal anti-myeloperoxidase (MPO7) for diagnosing acute leukaemia.
Journal of clinical pathology 1990;43(10):847-9.
1990: G Dolan; A P Jones; John T Reilly
Immunoblastic lymphoma presenting with syncope due to sinoatrial node disease.
Postgraduate medical journal 1990;66(775):395-7.
1989: D Barnett; J Storr; G A Buckley; John T Reilly
In vitro stimulation of B-CLL [corrected] induces differentiation and not proliferation.
British journal of haematology 1989;72(1):113.